1887

Abstract

We retrospectively analysed the incidence rate of reported cases of pertussis in Barcelona during 2009–2012 according to age, sex, type of medical centre and vaccination status. We included 748 confirmed or suspected cases, 613 (82.0 %) of which were confirmed by laboratory testing and the remaining 135 (18.0 %) by epidemiological evidence. The highest reported incidence of pertussis was amongst <1 year olds [96.1 per 100 000 person-years, 95 % confidence interval (CI): 84.3–109.1]. The majority of confirmed and suspected cases were reported in 2011 and 2012, and the total incidence (confirmed or suspected) was 6.3 (95 % CI: 5.6–6.9) and 4.2 (95 % CI: 3.6–4.7) per 100 000 person-years, respectively. Incidence increased significantly ( = 0.001) in 2011–2012 compared with 2009. Most confirmed cases occurred in children <1 year old (87.9 %). Cases were confirmed by real-time (RT)-PCR (87.5 %; 95 % CI: 81.3–87.6) and bacterial culture (13.7 %; 95 % CI: 11.0–17.1). We recommend performing RT-PCR in suspected cases with no epidemiological link to a confirmed case.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.079756-0
2014-12-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/12/1688.html?itemId=/content/journal/jmm/10.1099/jmm.0.079756-0&mimeType=html&fmt=ahah

References

  1. Begoña J., Meseguer M. A., Oliver A., Puig de la Bellacasa J. 2007 Microbiological Diagnosis of Bacterial Infections of the Lower Respiratory Tract, 2nd edn. Madrid: SEIMC (in Spanish);
    [Google Scholar]
  2. Bisgard K. M., Pascual F. B., Ehresmann K. R., Miller C. A., Cianfrini C., Jennings C. E., Rebmann C. A., Gabel J., Schauer S. L., Lett S. M. 2004; Infant pertussis: who was the source?. Pediatr Infect Dis J 23:985–989 [View Article][PubMed]
    [Google Scholar]
  3. Campins M., Moreno-Pérez D., Gil-de Miguel A., González-Romo F., Moraga-Llop F. A., Arístegui-Fernández J., Goncé-Mellgren A., Bayas J. M., Salleras-Sanmartí L. 2013; Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group. Enferm Infecc Microbiol Clin 31:240–253 (in Spanish) [View Article][PubMed]
    [Google Scholar]
  4. Campins-Martí M., Moraga-Llop F. A. 2004; Acellular pertussis vaccines for use among infants and young children. Expert Opin Pharmacother 5:807–817 [View Article][PubMed]
    [Google Scholar]
  5. Caro V., Guiso N., Alberti C., Liguori S., Burucoa C., Couetdic G., Doucet-Populaire F., Ferroni A., Papin-Gibaud S. other authors 2009; Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses. J Clin Microbiol 47:3197–3203 [View Article][PubMed]
    [Google Scholar]
  6. Celentano L. P., Massari M., Paramatti D., Salmaso S., Tozzi A. E. EUVAC-NET Group 2005; Resurgence of pertussis in Europe. Pediatr Infect Dis J 24:761–765 [View Article][PubMed]
    [Google Scholar]
  7. Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud (2013). [Whooping Cough Working Group 2012 Lecture Programme and Immunization Registry & Programme Review Vaccination Against Pertussis in Spain]. Madrid: Ministerio de Sanidad Servicios Sociales e Igualdad (in Spanish)
  8. Cornia P. B., Hersh A. L., Lipsky B. A., Newman T. B., Gonzales R. 2010; Does this coughing adolescent or adult patient have pertussis?. JAMA 304:890–896 [View Article][PubMed]
    [Google Scholar]
  9. Crespo I., Cardeñosa N., Godoy P., Carmona G., Sala M. R., Barrabeig I., Alvarez J., Minguel S., Camps N. other authors 2011; Epidemiology of pertussis in a country with high vaccination coverage. Vaccine 29:4244–4248 [View Article][PubMed]
    [Google Scholar]
  10. de Greeff S. C., de Melker H. E., van Gageldonk P. G., Schellekens J. F., van der Klis F. R., Mollema L., Mooi F. R., Berbers G. A. 2010; Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis . PLoS ONE 5:e14183 [View Article][PubMed]
    [Google Scholar]
  11. Dempsey A. F., Cowan A. E., Broder K. R., Kretsinger K., Stokley S., Clark S. J. 2009; Diagnosis and testing practices for adolescent pertussis among a national sample of primary care physicians. Prev Med 48:500–504 [View Article][PubMed]
    [Google Scholar]
  12. Diez-Domingo J., Ballester A., Baldó J. M., Planelles M. V., Villarroya J. V., Alvarez T., Carmen Peidró M., Calero P., Garcés M. D. other authors 2004; Incidence of pertussis in persons ≤15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults. J Infect 49:242–247 [View Article][PubMed]
    [Google Scholar]
  13. Forsyth K., Tan T., von König C. H., Caro J. J., Plotkin S. 2005; Potential strategies to reduce the burden of pertussis. Pediatr Infect Dis J 24:SupplS69–S74 [View Article][PubMed]
    [Google Scholar]
  14. Gabutti G., Rota M. C., Bonato B., Pirani R., Turlà G., Cucchi A., Cavallaro A. 2012; Hospitalizations for pertussis in Italy, 1999–2009: analysis of the hospital discharge database. Eur J Pediatr 171:1651–1655 [View Article][PubMed]
    [Google Scholar]
  15. García-Martínez J., Chaves F., Salto E., Otero J. R. 2006; Bordetella pertussis detection by real-time PCR, immunofluorescence and culture: prospective evaluation and molecular epidemiology. Enferm Infecc Microbiol Clin 24:500–504 (in Spanish) [View Article][PubMed]
    [Google Scholar]
  16. Giammanco A., Taormina S., Chiarini A., Dardanoni G., Stefanelli P., Salmaso S., Mastrantonio P. 2003; Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough. Vaccine 21:1924–1931 [View Article][PubMed]
    [Google Scholar]
  17. Gil A., Oyagüez I., Carrasco P., González A. 2001; Hospital admissions for pertussis in Spain, 1995–1998. Vaccine 19:4791–4794 [View Article][PubMed]
    [Google Scholar]
  18. Greenberg D. P., von König C. H., Heininger U. 2005; Health burden of pertussis in infants and children. Pediatr Infect Dis J 24:Suppl.S39–S43 [View Article][PubMed]
    [Google Scholar]
  19. Guiso N., Liese J., Plotkin S. 2011; The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14–15, 2010. Hum Vaccin 7:481–488 [View Article][PubMed]
    [Google Scholar]
  20. He Q., Schmidt-Schläpfer G., Just M., Matter H. C., Nikkari S., Viljanen M. K., Mertsola J. 1996; Impact of polymerase chain reaction on clinical pertussis research: Finnish and Swiss experiences. J Infect Dis 174:1288–1295 [View Article][PubMed]
    [Google Scholar]
  21. He Q., Barkoff A. M., Mertsola J., Glismann S., Bacci S. European Bordetella expert group (EUpertstrain) European surveillance network for vaccine-preventable diseases (EUVAC.NET) 2012; High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. Euro Surveill 17:20239[PubMed]
    [Google Scholar]
  22. Heininger U., Cherry J. D. 2006; Pertussis immunisation in adolescents and adults – Bordetella pertussis epidemiology should guide vaccination recommendations. Expert Opin Biol Ther 6:685–697 [View Article][PubMed]
    [Google Scholar]
  23. Koidl C., Bozic M., Burmeister A., Hess M., Marth E., Kessler H. H. 2007; Detection and differentiation of Bordetella spp. by real-time PCR. J Clin Microbiol 45:347–350 [View Article][PubMed]
    [Google Scholar]
  24. Lapaeva I. A., Mebel’ S. M., Pereverzev N. A. 1981; Effect of certain factors on the variability of strains of pertussis microbes. Zh Mikrobiol Epidemiol Immunobiol 3:53–58 (in Russian) [PubMed]
    [Google Scholar]
  25. Long S. S. 2009; Bordetella pertussis (pertussis) and others species. In Principles and Practice of Pediatric Infectious Diseases, 3rd edn. pp. 858–865 Edited by Long S. S., Pickering L. C., Prober C. P. New York: Churchill Livingstone;
    [Google Scholar]
  26. Manzanares S., Lafuente S., Martí M., Simon P., Gorrindo P., Caylà J. A. 2013; Incidence of whooping cough in the city of Barcelona between 1999 and 2011. Enferm Infecc Microbiol Clin 31:156–158 (in Spanish) [View Article][PubMed]
    [Google Scholar]
  27. Markov P. V., Crowcroft N. S. 2007; Modelling the unidentified mortality burden from thirteen infectious pathogenic microorganisms in infants. Epidemiol Infect 135:17–26 [View Article][PubMed]
    [Google Scholar]
  28. Miyashita N., Akaike H., Teranishi H., Kawai Y., Ouchi K., Kato T., Hayashi T., Okimoto N. 2013; Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients. BMC Infect Dis 13:129 [View Article][PubMed]
    [Google Scholar]
  29. Montella S., De Stefano S., Sperlì F., Barbarano F., Santamaria F. 2007; Increased risk of chronic suppurative lung disease after measles or pertussis in non-vaccinated children. Vaccine 25:402–403 [View Article][PubMed]
    [Google Scholar]
  30. Mooi F. R., Van Der Maas N. A., De Melker H. E. 2014; Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin. Epidemiol Infect 142:685–694 [View Article][PubMed]
    [Google Scholar]
  31. Nuolivirta K., Koponen P., He Q., Halkosalo A., Korppi M., Vesikari T., Helminen M. 2010; Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis. Pediatr Infect Dis J 29:1013–1015 [View Article][PubMed]
    [Google Scholar]
  32. Paddock C. D., Sanden G. N., Cherry J. D., Gal A. A., Langston C., Tatti K. M., Wu K. H., Goldsmith C. S., Greer P. W. other authors 2008; Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 47:328–338 [View Article][PubMed]
    [Google Scholar]
  33. Paksu M. S., Akgün M., Karadağ A., Aşılıoğlu N., Belet N., Şensoy G. 2013; Fulminant pertussis in very young infants: two cases and review of the literature. Turk J Pediatr 55:426–429[PubMed]
    [Google Scholar]
  34. Plans P. 2005; Evaluation of vaccination programmes through serological studies and distributed vaccines. Gac Sanit 19:456–462 (in Spanish) [View Article][PubMed]
    [Google Scholar]
  35. Poddar S. K. 2004; Differential detection of B. pertussis from B. parapertussis using a polymerase chain reaction (PCR) in presence of SYBR green1 and amplicon melting analysis. Mol Cell Probes 18:429–435 [View Article][PubMed]
    [Google Scholar]
  36. Sala-Farré M. R., Arias-Varela C., Recasens-Recasens A., Simó-Sanahuja M., Muñoz-Almagro C., Pérez-Jové J. 2013; Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine. Enferm Infecc Microbiol Clin 8:S0213-005X(13)00298-X[PubMed]
    [Google Scholar]
  37. Sanz Moreno J. C., De Ory Manchón F., González Alonso J., de La Torre J. L., Salmerón F., Limia A., Tello O., Pachón I., Amela C. other authors 2002; Laboratory diagnosis of pertussis. Role of serology. Enferm Infecc Microbiol Clin 20:212–218 (in Spanish) [PubMed] [CrossRef]
    [Google Scholar]
  38. Schmidt J. E., Tozzi A. E., Rava L., Glismann S. 2001; The EUVAC-NET survey: national pertussis surveillance systems in the European Union, Switzerland, Norway, and Iceland. Euro Surveill 6:98–104[PubMed]
    [Google Scholar]
  39. Solano R., Gómez-Barroso D., Simón F., Lafuente S., Simón P., Rius C., Gorrindo P., Toledo D., Caylà J. A. 2014; Retrospective space-time cluster analysis of whooping cough, re-emergence in Barcelona, Spain, 2000–2011. Geospat Health 8:455–461[PubMed] [CrossRef]
    [Google Scholar]
  40. Tan T., Trindade E., Skowronski D. 2005; Epidemiology of pertussis. Pediatr Infect Dis J 24:Suppl.S10–S18 [View Article][PubMed]
    [Google Scholar]
  41. Tatti K. M., Martin S. W., Boney K. O., Brown K., Clark T. A., Tondella M. L. 2013; Qualitative assessment of pertussis diagnostics in United States laboratories. Pediatr Infect Dis J 32:942–945 [View Article][PubMed]
    [Google Scholar]
  42. Tozzi A. E., Pandolfi E., Celentano L. P., Massari M., Salmaso S., Ciofi degli Atti M. L. EUVAC-NET Study Group 2007; Comparison of pertussis surveillance systems in Europe. Vaccine 25:291–297 [View Article][PubMed]
    [Google Scholar]
  43. Vieira M., Dias J. G., Queirós L., Correia A. M. 2010; Pertussis hospitalizations: northern region of Portugal, 2000–2006. Acta Med Port 23:605–612 (in Portuguese) [PubMed]
    [Google Scholar]
  44. Walsh P., Overmeyer C., Kimmel L., Feola M., Pusavat J., Nguyen T. A., Kuan S., Emery K., Rosengreen M. other authors 2008; Prevalence of Bordetella pertussis and Bordetella parapertussis in samples submitted for RSV screening. West J Emerg Med 9:135–140[PubMed]
    [Google Scholar]
  45. Ward J. I., Cherry J. D., Chang S. J., Partridge S., Keitel W., Edwards K., Lee M., Treanor J., Greenberg D. P. other authors 2006; Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized acellular pertussis vaccine trial (APERT). Clin Infect Dis 43:151–157 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.079756-0
Loading
/content/journal/jmm/10.1099/jmm.0.079756-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error